At only pennies per dose, metformin is a Type 2 diabetes drug with distant roots in Medieval folk medicine and a powerful capacity to reduce body weight, fat mass, circulating glucose—and prevent the disorder altogether ...
A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D).
Researchers at Centro per le Malattie Endocrine e Metaboliche, Italy, have found that a single 30-minute aerobic exercise session significantly reduced 1-hour post-load plasma glucose levels and improved insulin sensitivity ...
Pediatric patients aged 10 to 19 years old diagnosed with COVID-19 have a higher risk of new-onset type 2 diabetes within six months compared to those diagnosed with other respiratory infections, according to researchers ...
The concentration of glucose in the blood of humans continuously changes in response to what they eat and the activities they engage in. While many studies have investigated changes in blood glucose, the role of different ...
Research led by the Massachusetts Institute of Technology Sloan School of Management, Cambridge, has found that an intensive food-as-medicine program showed no improvement in glycemic control in patients with type 2 diabetes ...
The microbiome offers a motherlode of data about health and disease, and new findings suggest that antibodies to gut microbes can determine how well patients respond to a new monoclonal antibody drug that delays the onset ...
Diabetes is a condition in which the body produces too little or no insulin. Diabetics thus depend on an external supply of this hormone via injection or pump.
Aug 23, 2023
0
97
Research led by the People's Hospital of Zhengzhou University, China, has found a connection between gut microbiota and distal symmetric polyneuropathy. In a paper, "Gut microbiota modulate distal symmetric polyneuropathy ...
Research led by the University of Texas Health Science Center, San Antonio, Texas, has looked into premature brain aging in individuals with type 1 diabetes.
